P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status

INTRODUCTION: Measurement of amyloid beta (Aβ40 and Aβ42) and tau (phosphorylated tau [p‐tau] and total tau [t‐tau]) in cerebrospinal fluid (CSF) can be utilized to differentiate clinical and preclinical Alzheimer's disease dementia (AD) from other neurodegenerative processes. METHODS: CSF biom...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement (Amst)
Autors principals: Campbell, Michelle R., Ashrafzadeh‐Kian, Susan, Petersen, Ronald C., Mielke, Michelle M., Syrjanen, Jeremy A., van Harten, Argonde C., Lowe, Val J., Jack, Clifford R., Bornhorst, Joshua A., Algeciras‐Schimnich, Alicia
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Cerebrospinal Fluid Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129859/
https://ncbi.nlm.nih.gov/pubmed/34027020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12190
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars